ImetelChat

Forth!

Although I think that scarlet will surprise us all way before 2022. Be that with more financing, sales to institutions with little notice so that they can fund an AML trial, or something. It feels like there is ahead of steam with developments. Fanciful wishful thinking I know.

The large number of Options that have been open on Geron for Jan 2021 all summer is intriguing. Some possible event then, although no idea what it could be.

I've been trying to confirm that the abstracts will be available on the 5th, however it's either been removed or just existing in my lockdown imagination. Checking the ASH website says that this year notifications that an abstract has been accepted can be sent up to the 12 November, so I guess that ...

The abstracts are online the same day as the geron earnings. Read into it what you will.

Crossover would only be allowed after they have overwhelming results and it would be unethical to leave people on a placebo. Which would basically mean that the drug is approved and they are going through the formalities. I doubt this would be something we would get much information from scarlet on....

Mentioning the Ash abstracts in the last conference was unusual and is possibly pointing to the fact that they already know.

I would still dearly love to hear when this is going to be available for compassionate use. It's an old JnJ wound that still hasn't healed. If the drug is as amazing as we hope then alot of people have suffered over the last years in this not being out there. But going forward, at what point could t...

Other options are more dilution and then an reverse split to keep it above a dollar.

While none of us want to consider this seriously it's still an option that gives me nightmares.

Timing?

If they wait and see what the results are like in the current trial and the nature of what (hopefully) will be announced this month they would know more about what they are buying.

If it is a normal P3 then we have another year or two before this could be acquired.

Afternoon,

Did any of the awards strike any one as unusually or far to high? Nothing to be worried about?

The timing could be interesting. At least a months grace before the end of Q1, so they can't be accused of insider trading when they announce what has happened with the FDA.

"And the people working on IMET at Janssen now are working at Geron … so what does this tell you ?" Just to play devils advocate. It could mean that JNJ where going to lay them all off as there project had been discontinued and due to all the law suits they had no other projects to move them to and ...

My hopes for ASH this year where none existent. I had assume they would basically skip this year as they have been to busy hiring new staff, starting the P3 and basically rebuilding the company from scratch. The meeting early next year with the FDA and RW data update at a conference is a possibility...

Great news.

Still can't get my head around how they can take so long to recruit patients when there is 70 sites involved,

Is it normal for some sites in a trail to not actually recruit? Or only have few people involved over the entire trail length?

Is it normal for it to be released in advance? I don't recall them doing it at this conference before.

Thanks again for all your good work as a moderator and for your insights. I had assumed that the lack of activity on this board at the moment is because there was no new information to discus and rehashing was pointless. As we tend to stick to the science rather than the stock price manipulation tha...

Listening to the conference call, the answer to the second part of the first question was 57 million remaining of the shelf offering. Have they already diluted alot more than the 1.8 million you mention? I agree with you, selling at these prices really does make me doubt that anything good will happ...

Also much appreciated.
If this board is lost like the yahoo one I think I would scream.

The fact that the meetings with the FDA are being widely publicised gives people confidence that nothing unexpected will happen till then. The P3 will start and with the quick turnaround for TI by early next next year they should have enough evidence to get the SP rolling. People making a quick buck...

I have a hope that there is a cunning plan.....

Chip could drop some positive news to counter the dilution vote. Doubt it but possible.
More likely the vote gets passed, stock tanks and then a few months later, with positive news they sell into the spikes.
Anything is possible at the moment.

I think that the current lack of vision, partners and combos is holding the share price down and will continue to do so. MDS is funded, MF isn't. I don't think any one expects scarlet to take geron forward with just the MDS trail. That makes further dilution inevitable. I think that the share price ...